Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

Rationale: Less invasive, nonsurgical approaches are needed to treat severe emphysema.Objectives: To evaluate the effectiveness and safety of the Spiration Valve System (SVS) versus optimal medical management.Methods: In this multicenter, open-label, randomized, controlled trial, subjects aged 40 ye...

全面介紹

Saved in:
書目詳細資料
Main Authors: Gerard J. Criner, Antoine Delage, Kirk Voelker, D. Kyle Hogarth, Adnan Majid, Michael Zgoda, Donald R. Lazarus, Roberto F. Casal, Sadia Benzaquen, Robert Holladay, Adam Wellikoff, Karel Calero, Mark J. Rumbak, Paul Branca, Muhanned Abu‐Hijleh, Jorge M. Mallea, Ravi Kalhan, Ashutosh Sachdeva, C. Matthew Kinsey, Carla Lamb, Michael F. Reed, Wissam Abouzgheib, Phillip V. Kaplan, Gregory X. Marrujo, David W. Johnstone, Mario Gasparri, Arturo A. Meade, Christopher A. Hergott, Chakravarthy Reddy, Richard A. Mularski, Amy Hajari Case, Samir Makani, Ray W. Shepherd, Benson Chen, Gregory E. Holt, Simon Martel
格式: Artigo
語言:英语
出版: 2019
在線閱讀:https://doi.org/10.1164/rccm.201902-0383oc
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

https://doi.org/10.1164/rccm.201902-0383oc

相似書籍